Key result
Multiplex PCR detects pathogens in ~85% of rapid test-negative ARI outpatients, primarily rhinovirus/enterovirus and RSV.
Why the study?
This study explored the distribution and genetic characteristics of respiratory pathogens in outpatients with acute respiratory infections in Yangon, Myanmar, during the 2023 rainy season.
What is the distribution and genetic diversity of respiratory pathogens among rapid diagnostic test-negative ARI outpatients in Myanmar?
Observational (n=267)
What is the distribution and genetic diversity of respiratory pathogens among rapid diagnostic test-negative ARI outpatients in Myanmar?
Multiplex PCR reveals high rates of respiratory pathogens, predominantly rhinovirus/enterovirus, in patients testing negative by standard rapid diagnostic tests in Myanmar.
Rapid diagnostic tests miss most respiratory pathogens in ARI outpatients; hypothesis-generating for multiplex PCR utility in resource-limited settings.
This study explored the distribution and genetic characteristics of respiratory pathogens in outpatients with acute respiratory infections (ARIs) in Yangon, Myanmar, during the 2023 rainy season. Among 267 patients who tested negative for influenza, RSV, and SARS-CoV-2 using rapid diagnostic tests, 84.6% were positive for at least one pathogen according to a multiplex polymerase chain reaction (PCR) assay, the BioFire® FilmArray® Respiratory Panel 2.1. The most common viruses detected were rhinovirus/enterovirus (RV/EV) at 37.8%, respiratory syncytial virus (RSV) at 22.4%, and human metapneumovirus (hMPV) at 10.0%. These pathogens co-circulated mainly from July to September, with RV/EV consistently predominant. Symptom comparison among RV/EV-, RSV-, and hMPV-infected patients showed similar clinical features, though fever was more common in hMPV cases. Among RV/EV-positive patients, 59.3% had single infections, while 40.7% experienced co-infections, especially with RSV and adenovirus. Genotyping identified 28 types from five species, primarily RV-A and RV-C, which were genetically diverse. One EV-D68 case was also found, emphasizing its potential risk. This study underscores the genetic diversity and clinical impact of RV/EV and stresses the importance of ongoing molecular surveillance in Myanmar’s post-COVID-19 context to inform effective public health responses.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) conducted an observational in Acute respiratory infections (n=267). Multiplex polymerase chain reaction (PCR) assay (BioFire FilmArray Respiratory Panel 2.1) was evaluated on Positivity for at least one respiratory pathogen. Multiplex PCR testing of rapid diagnostic test-negative ARI outpatients detected at least one pathogen in 84.6% of cases, most commonly rhinovirus/enterovirus (37.8%) and RSV (22.4%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: